-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
CompilationFan Dongdong
A few days ago, Pfizer has voluntarily recalled 12 batches of quit smoking drug Chantix.
In a statement issued recently, the U.
In this regard, the FDA pointed out that nitrosamines are ubiquitous in life, and everyone will be exposed to nitrosamines to a certain extent, because these substances are ubiquitous in water and food, such as pickled food, barbecue, dairy products and vegetables
The FDA stated that “in theory, long-term intake of N-nitroso-neicotabine may be associated with an increased risk of potential human tumors, but taking Chantix itself does not pose a direct risk to patients
Chantix is Pfizer's blockbuster smoking cessation drug, which can effectively relieve the craving for nicotine and withdrawal symptoms, and can help reduce the pleasure of smoking during the 12-week treatment
So far, Pfizer has not received any adverse event reports related to the recall
Pfizer said in June that the company would suspend Chantix's global shipments due to nitrosamine impurities, and the drug is currently in short supply in the United States
In recent years, there have been frequent recalls of foreign drugs and medical devices
Reference source:
1.
2.
